Tag: Evotec

Evotec receives €3 million payment from Sanofi

stem cells
Evotec AG announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached its second beta cell therapy milestone, resulting in a payment of €3 million to Evotec.

Evotec and Sanofi join forces to fight infectious diseases

microbiology plates
Evotec signed a transaction agreement with Sanofi to integrate Sanofi’s infectious disease unit into its organisation. Evotec will also licence-in the majority of Sanofi’s infectious disease research portfolio and initiatives.

Evotec and Celgene started oncology partnership

Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology.

Evotec expands its CRISPR service offering with a licence from ERS Genomics

Evotec AG announced that it has expanded its CRISPR service offering with the addition of a licence from ERS Genomics Limited. With this licence, Evotec gains access to the leading technology for gene editing.

Evotec launched its unique drug development solution

Evotec AG has launched its accelerated drug development service INDiGO. With the launch of INDiGO, Evotec’s expertise and capabilities are uniquely combined to deliver better drug candidates faster and more efficiently.

Evotec and Sanofi will create a new innovation platform in France

test tube
Evotec AG and Sanofi have entered into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform near Lyon, France.